Multiple sclerosis : clinical and laboratory research
-
Randomized Controlled Trial
Brain and lesion segmentation in multiple sclerosis using fully convolutional neural networks: A large-scale study.
To investigate the performance of deep learning (DL) based on fully convolutional neural network (FCNN) in segmenting brain tissues in a large cohort of multiple sclerosis (MS) patients. ⋯ The results from this large-scale study suggest that deep FCNN can automatically segment MS brain tissues, including lesions, with high accuracy.